Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Quarterly adjusted earnings per share totaled $2.57 (+40%), beating the street view of $2.20. Target reported sales of $25.45 billion (+2.7%), exceeding the analyst consensus of $25.229 billion.On CNBC's "Mad Money Lightning Round," Jim Cramer said Target Corporation (NYSE:TGT) reported a "very, very good" quarter.
在CNBC的 「瘋狂金錢閃電回合」 中，吉姆·克萊默說，塔吉特公司（紐約證券交易所代碼：TGT）公佈的季度業績 「非常非常好」。
"It does yield 3%, which is actually quite good," he added.
他補充說：「它的收益率確實爲3％，這實際上相當不錯。」
On Aug. 21, Target posted stellar second-quarter results outperformed earnings and sales expectations and prompted an optimistic boost to its full-year profit outlook.
8月21日，塔吉特公佈了出色的第二季度業績，表現超過了收益和銷售預期，並推動了其全年利潤前景的樂觀提振。
Quarterly adjusted earnings per share totaled $2.57 (+40%), beating the street view of $2.20. Target reported sales of $25.45 billion (+2.7%), exceeding the analyst consensus of $25.229 billion.
季度調整後每股收益總額爲2.57美元（+40％），超過了2.20美元的街景。塔吉特公佈的銷售額爲254.5億美元（增長2.7％），超過了分析師共識的252.29億美元。
Cramer also likes Zoetis Inc. (NYSE:ZTS).
克萊默還喜歡佐提斯公司（紐約證券交易所代碼：ZTS）。
On Aug. 6, Zoetis reported better-than-expected second-quarter financial results and raised its 2024 guidance above estimates. The animal health company reported second-quarter revenue of $2.36 billion, up 8% year-over-year on reported and 11% on an operational basis, beating the consensus of $2.31 billion.
8月6日，Zoetis公佈的第二季度財務業績好於預期，並將2024年的預期提高到預期以上。這家動物健康公司公佈的第二季度收入爲23.6億美元，同比增長8％，運營收入同比增長11％，超過了23.1億美元的市場共識。
When asked about PROCEPT BioRobotics Corporation (NASDAQ:PRCT), he said, "It's been a rocket, but I think if you're going to be in robotics, you have to be in ISRG."
當被問及Procept BioRobotics Corporation（納斯達克股票代碼：PRCT）時，他說：「這是一枚火箭，但我認爲，如果你要進入機器人領域，就必須加入ISRG。」
On Sept. 3, Truist Securities analyst Richard Newitter maintained PROCEPT BioRobotics with a Buy and raised the price target from $74 to $95.
9月3日，Truist Securities分析師理查德·內維特維持了Procept BioRobotics的買入，並將目標股價從74美元上調至95美元。
"I've liked Con Ed for, I don't know, maybe 70 points," Cramer said when asked about Consolidated Edison, Inc. (NYSE:ED). "As long as it's around, above three, I think the stock can still project itself even higher."
當被問及聯合愛迪生公司（紐約證券交易所代碼：ED）時，克萊默說：「我不知道，我喜歡Con Ed可能是70個積分。」「只要它在三點以上，我認爲該股仍然可以預測得更高。」
On Aug. 1, Consolidated Edison reported quarterly earnings of 59 cents per share which beat the analyst consensus estimate of 57 cents per share. The company reported quarterly sales of $3.22 billion which beat the analyst consensus estimate of $3.18 billion.
8月1日，聯合愛迪生公佈的季度每股收益爲59美分，超過了分析師共識估計的每股57美分。該公司公佈的季度銷售額爲32.2億美元，超過了分析師共識估計的31.8億美元。
Price Action:
價格走勢：
- PROCEPT BioRobotics shares fell 5% to settle at $75.06 on Tuesday.
- Zoetis shares gained 0.04% to close at $183.57.
- Target shares fell 1.2% to close at $151.80 during Tuesday's session.
- Consolidated Edison shares rose 1.7% to settle at $103.28 on Tuesday.
- 週二，Procept BioRobotics股價下跌5％，收於75.06美元。
- 佐伊蒂斯股價上漲0.04％，收於183.57美元。
- 在週二的交易中，目標股價下跌1.2％，收於151.80美元。
- 週二，愛迪生合併股價上漲1.7％，收於103.28美元。
- Dow Tumbles Over 600 Points, Nasdaq Dips 3% Amid Plunge In Nvidia: Fear Index Remains In 'Greed' Zone
- 道瓊斯指數暴跌超過600點，納斯達克指數下跌3％：恐懼指數仍處於 「貪婪」 區域
Image: Shutterstock
圖片：Shutterstock
